GGrantIndex
← Leaderboards

Eileen Remold-O'Donnell

Immune Disease Institute, Inc.

$8,017,506
Attributed
$8,017,506
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $840K · FY200517
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$8,017,506 · 9

By mechanism

R01$4,347,102 · 2
R21$2,581,462 · 5
P01$1,088,942 · 2

Top collaborators

No co-investigators on record.

Most similar at Immune Disease Institute, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationResponseCellsProteinsElastasesProtease InhibitorCathepsin GEndopeptidasesInflammatoryHaemophilus InfluenzaeInhibitor/AntagonistCytokineInjuryPeptide HydrolasesImmune ResponseBlood CellsLymphocyteImmunePhenotypeSurfaceInfectionChronicAnti-Bacterial AgentsLung

Grant awards (26)

Regulation of Th17 immune responses by serpinB1$221,250
R21 · FY2017 · AI · contact PI
Regulation of Th17 immune responses by serpinB1$265,500
R21 · FY2016 · AI · contact PI
Regulation of NETosis in antibacterial lung defense$175,500
R21 · FY2014 · AI · contact PI
Regulation of NETosis in antibacterial lung defense$306,250
R21 · FY2013 · AI · contact PI
MNEI/SerpinB1: A modulator of innate pulmonary defense$359,400
R01 · FY2010 · HL · contact PI
Impaired integrin-dependent function of WASP-deficient platelets$196,413
R21 · FY2010 · HL · contact PI
MNEI/SerpinB1: A modulator of innate pulmonary defense$165,600
R01 · FY2010 · HL · contact PI
Impaired integrin-dependent function of WASP-deficient platelets$64,347
R21 · FY2010 · HL · contact PI
MNEI/SerpinB1: A modulator of innate pulmonary defense$525,000
R01 · FY2009 · HL · contact PI
Impaired integrin-dependent function of WASP-deficient platelets$315,000
R21 · FY2009 · HL · contact PI
MNEI/SerpinB1: A modulator of innate pulmonary defense$473,500
R01 · FY2008 · HL · contact PI
SERPINB1/MNEI: Role in innate immune defense against influenza virus infection$232,252
R21 · FY2008 · AI · contact PI
MNEI/SerpinB1: A modulator of innate pulmonary defense$473,500
R01 · FY2007 · HL · contact PI
SERPINB1/MNEI: Role in innate immune defense against influenza virus infection$284,100
R21 · FY2007 · AI · contact PI
Defects of Thymic Output in Wiskott-Aldrich Syndrome$236,750
R21 · FY2006 · HL · contact PI
Defects of Thymic Output in Wiskott-Aldrich Syndrome$284,100
R21 · FY2005 · HL
ROLE OF PROTEASE IN INFECTION &INFLAMMATION OF COPD$425,700
R01 · FY2003 · HL
ROLE OF PROTEASE IN INFECTION &INFLAMMATION OF COPD$425,700
R01 · FY2002 · HL
CD43 AND REGULATION OF BLOOD CELL ADHESION$172,411
P01 · FY2002 · HL
ROLE OF PROTEASE IN INFECTION &INFLAMMATION OF COPD$425,700
R01 · FY2001 · HL
CELLULAR DEFECTS IN THE WISKOTT/ALDRICH SYNDROME$328,434
R01 · FY2001 · AI
CORE--PATIENT MUTATION ANALYSIS$220,513
P01 · FY2001 · HL
CORE--PATIENT MUTATION ANALYSIS$426,552
P01 · FY2000 · HL
ROLE OF PROTEASE IN INFECTION &INFLAMMATION OF COPD$425,700
R01 · FY2000 · HL
CELLULAR DEFECTS IN THE WISKOTT/ALDRICH SYNDROME$318,868
R01 · FY2000 · AI
CD43 AND REGULATION OF BLOOD CELL ADHESION$269,466
P01 · FY2000 · HL